Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Fadi Issa has received a gentleMACST Octo Dissociator from global biotechnology company Miltenyi Biotec following a competition draw.

© NDS
Dr Fadi Issa receiving the prize from Clare Marchant, Senior Account Manager at Miltenyi Biotec

The new tissue dissociator will help Dr Issa perform important experiments using standardised and reliable methods. This is particularly vital in the analysis of samples from clinical studies. The tissue dissociator breaks up lumps of tissue into either a cell suspension for cellular assays or a homogenate for the isolation of molecules, such as RNA or protein.

 

Making our experiments more efficient, reliable and standardised will really help advance our goals. - Dr Fadi Issa

Dr Issa, who is a clinician scientist in the Transplantation Research Immunology Group (TRIG) at the Nuffield Department of Surgical Sciences, will use the equipment to dissociate mouse heart, spleen and skin as well as human skin, intestine and umbilical cord. Breaking the tissue up into cells will enable him to isolate specific cell groups in order to analyse or culture the cells.

He said: 'I am very grateful to Miltenyi for providing us with this critical piece of equipment. Making our experiments more efficient, reliable and standardised will really help advance our goals. We have been working with Miltenyi for a number of years in both basic, translational and clinical studies and look forward to continuing this valuable relationship.'

Miltenyi Biotec donated the equipment as part of an international prize draw, in which professional graffiti and concept artist Lars Kesseler designed and hand-crafted a special edition of the prize. He had previously designed a different instrument - the autoMACS Pro Separator - to help celebrate the company's 25th anniversary.

Miltenyi Biotec is headquartered near Cologne in Bergisch Gladbach, Germany, and has offices across the globe. The company is a provider of products and services that support scientists, clinical researchers, and physicians across basic research, translational research, and clinical applications.

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Results of the REF 2021: congratulations and thank you

Today, the UK funding bodies have published the results of the UK’s most recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

NDS projects awarded CRUK Oxford Cancer Development Fund

Two research projects at the Nuffield Department of Surgical Sciences (NDS) have been awarded pump-prime funding from this year’s CRUK Oxford Centre Development Fund.

Blog posts

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.

Wrap up of 2021

After a brilliant year of hard work and dedication, the SITU team has done some reflection on 2021, focusing on key events, trial progression, and more. Read on to discover how the year 2021 went for the SITU team...